NAROPIN Solution for Injection
Ropivacaine
2 mg/ml
ALLERGAN SALES, LLC.
| Pack size | 5 Ampoule (20ml) |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 13.42 AED |
Available as:
Indications
NAROPIN Solution for Injection is used for:
Local Anesthesia
Adult Dose
Epidural/Caudal Anesthesia
75-200 mg (15-30 mL of 0.5%-1% solution)
Major Nerve Block
175-250 mg (35-50 mL) of 0.5% solution
75-300 mg (10-40 mL) of 0.75% solution
Field Block
5-200 mg (1-40 mL) of 0.5% solution
Labor Pain
20-40 mg (10-20 mL) initial of 0.2% solution, THEN
12-28 mg/hr (6-14 mL/hr) of 0.2% solution OR
20-30 mg/hr (10-15 mL/hr) continuous infusion of 0.2% solution
Post-Op Pain
Peripheral Nerve Block
5-10 mL/hr continuous infusion of 0.2% solution
Lumbar or Thoracic Epidural
6-14 mL/hr continuous infusion of 0.2% solution
Infiltration/ Minor Nerve Block
1-100 mL dose of 0.2% solution
1-40 mL dose of 0.5% solution
Child Dose
Renal Dose
Administration
Contra Indications
Hypersensitivity to ropivacaine or amide-type local anesthetics, sensitivity to parabens
Obstetrical paracervical block anesthesia
Precautions
History of malignant hyperthermia
DO NOT use solutions with epinephrine in distal areas of body (eg, digit, nose, ear)
Use preservative-free preparations for spinal or epidural anesthesia
Monitor patient's state of consciousness following the injection; anxiety, dizziness, restlessness, tremors, depression, or blurred vision may be signs of CNS toxicity
Addition of vasoconstrictor, epinephrine, will promote local hemostasis, decrease systemic absorption, and increase duration of action
Respiratory arrest reported with use
Seizures reported with systemic toxicity
Pregnancy-Lactation
Pregnancy Category: C
Lactation: not known if excreted in breast milk
Interactions
Adverse Effects
Side effects of Ropivacaine :
Frequency Not Defined
Bradycardia, myocardial depression, , cardiac arrhythmias, edema, hypotension, cardiovascular collapse, cardiac arrest, palpitation, tachycardia, anginal pain, hypertension (epinephrine-containing solutions)
Anxiety, apprehension, chills, headache, restlessness, nervousness, disorientation, confusion, dizziness, tremors, twitching, shivering, seizures; CNS depression manifested restlessness, tremors, drowsiness, unconsciousness, tinnitus
Nausea, vomiting
Blurred vision, miosis
Respiratory arrest, status asthmaticus
Anaphylactoid reactions (sometimes fatal)
Mechanism of Action
Local anesthetics prevent generation/conduction of nerve impulses by reducing sodium permeability & increasing action potential threshold
Note
NAROPIN 2 mg/ml Solution for Injection manufactured by ALLERGAN SALES, LLC.. Its generic name is Ropivacaine. NAROPIN is availble in Saudi Arabia.
Farmaco SA drug index information on NAROPIN Solution for Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.